Viewing Study NCT04350593


Ignite Creation Date: 2025-12-25 @ 1:03 AM
Ignite Modification Date: 2026-01-04 @ 11:10 PM
Study NCT ID: NCT04350593
Status: COMPLETED
Last Update Posted: 2022-06-10
First Post: 2020-04-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Dapagliflozin in Respiratory Failure in Patients With COVID-19
Sponsor: Saint Luke's Health System
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None sodium-glucose cotransporter-2 inhibitor (SGLT2i) View
None dapagliflozin View
None COVID-19 View